CAS RN: 875320-31-3
JNJ26854165(Quisinostat) 2HCl
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250318
100mg / 250mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 875320-31-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Shenzhen
Inquiry
875320-31-3 / N-hydroxy-2-[4-[[(1-methylindol-3-yl)methylamino]methyl]piperidin-1-yl]pyrimidine-5-carboxamide;dihydrochloride
Standard CAS: 875320-31-3
Multi CAS: Yes
Basic Information
copy
CAS
875320-31-3 copy
Multi CAS
Yes copy
Molecular Formula
C21H28CL2N6O2 copy
Molecular Weight
467.400000 copy
Exact Mass
466.165080 copy
InChI
InChI=1S/C21H26N6O2.2ClH/c1-26-14-17(18-4-2-3-5-19(18)26)11-22-10-15-6-8-27(9-7-15)21-23-12-16(13-24-21)20(28)25-29;;/h2-5,12-15,22,29H,6-11H2,1H3,(H,25,28);2*1H copy
InChIKey
NRUIZESXVMJDKR-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
31 copy
Aromatic heavy atom count
15 copy
Fraction Csp3
0.38 copy
Rotatable bonds
6 copy
H-bond acceptors
7 copy
H-bond donors
3 copy
Molar refractivity
125.34 copy
TPSA
95.31 copy
LogP / Solubility
WLOGP
2.94 copy
MLOGP
2.62 copy
XLogP3
2.94 copy
Consensus LogP
2.83 copy
Log S (ESOL)
-4.55 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-5.51 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-5.86 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-3.49 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy